Lowe Lintas has been named the brand and communications partner for Cofsils, part of the Cipla Health portfolio, following a competitive pitch involving several top creative agencies in India.
Cofsils, a recognised name in the throat relief category, offers a wide range of products including throat lozenges, cough drops, and cough syrup. With this appointment, Lowe Lintas will oversee the end-to-end integrated brand strategy and communications for the entire Cofsils portfolio.
The agency’s scope of work includes brand strategy, creative development, digital-first storytelling, and healthcare professional (HCP) communication. The overarching goal is to establish Cofsils as the go-to brand at the first sign of throat discomfort.
Shivam Puri, Managing Director and CEO of Cipla Health, said, “From strategic insights to creative storytelling, Lowe Lintas consistently impressed us with their depth of thinking and consumer empathy. We’re confident they are the right partner to help Cofsils unlock new growth pathways.”
The appointment strengthens Lowe Lintas’ ongoing partnership with Cipla Health and further reinforces its leadership in the health and wellness communication space.
Subramanyeswar S, Group CEO – India & CSO – APAC, MullenLowe Global, commented, “Earning repeat trust is the highest compliment. We are proud to deepen our partnership with Cipla Health. Together, we look forward to shaping a healthier future for people.”
Anaheeta Goenka, COO of Lowe Lintas, added, “We’re thrilled to partner with Cofsils on this exciting mandate. Winning this pitch was no small feat - the task at hand is both challenging and inspiring. Reigniting desire for a challenger brand and shifting consumer preference in a cluttered market will demand the best of our strategic and creative strengths.”
